Anti-TNF antibodies and methotrexate in the treatment of autoimmune disease

Details for Australian Patent Application No. 2012202134 (hide)

Owner The Kennedy Institute of Rheumatology

Inventors Feldman, Marc; Maini, Ravinder Nath

Agent FB Rice

Pub. Number AU-A-2012202134

Parent 2011200206

Filing date 12 April 2012

Wipo publication date 3 May 2012

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/505 (2006.01) - Pyrimidines

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

3 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202134

3 May 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202135-Replaceable staple cartridge

2012202133-Positioning arrangement for fitting an interchangeable milling assembly of a road-building machine